132 related articles for article (PubMed ID: 31096787)
21. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis.
Reithmeier-Rost D; Hill J; Elvin SJ; Williamson D; Dittmann S; Schmid A; Wilharm G; Sing A
Microbes Infect; 2007 Jul; 9(8):997-1002. PubMed ID: 17556003
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague.
Splettstoesser WD; Rahalison L; Grunow R; Neubauer H; Chanteau S
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):149-55. PubMed ID: 15145459
[TBL] [Abstract][Full Text] [Related]
23. [Dynamics of F1 antibody responses to
Meng WW; ; Wang XH; ; ; Luo T; Li B; ; Wang QG; Guo R; Dai X; Zhang YJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):353-357. PubMed ID: 28395471
[No Abstract] [Full Text] [Related]
24. [The approbation of technique of mass spectrometry with matrix-activated laser desorption/ionization for identification of plague agent].
Afanas'ev MV; Ostiak AS; Balakhonov SV
Klin Lab Diagn; 2014 Aug; 59(8):39-43. PubMed ID: 25552052
[TBL] [Abstract][Full Text] [Related]
25. Rapid Multiplexed Proteomic Screening for Primary Immunodeficiency Disorders From Dried Blood Spots.
Collins CJ; Chang IJ; Jung S; Dayuha R; Whiteaker JR; Segundo GRS; Torgerson TR; Ochs HD; Paulovich AG; Hahn SH
Front Immunol; 2018; 9():2756. PubMed ID: 30564228
[No Abstract] [Full Text] [Related]
26. Rapid and sensitive detection of Yersinia pestis using amplification of plague diagnostic bacteriophages monitored by real-time PCR.
Sergueev KV; He Y; Borschel RH; Nikolich MP; Filippov AA
PLoS One; 2010 Jun; 5(6):e11337. PubMed ID: 20596528
[TBL] [Abstract][Full Text] [Related]
27. Yersinia pestis YadC: a novel vaccine candidate against plague.
Murphy BS; Wulff CR; Garvy BA; Straley SC
Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
[TBL] [Abstract][Full Text] [Related]
28. Surface plasmon resonance imaging of pathogens: the Yersinia pestis paradigm.
Huynh HT; Gotthard G; Terras J; Aboudharam G; Drancourt M; Chabrière E
BMC Res Notes; 2015 Jun; 8():259. PubMed ID: 26105071
[TBL] [Abstract][Full Text] [Related]
29. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.
Powell BS; Andrews GP; Enama JT; Jendrek S; Bolt C; Worsham P; Pullen JK; Ribot W; Hines H; Smith L; Heath DG; Adamovicz JJ
Biotechnol Prog; 2005; 21(5):1490-510. PubMed ID: 16209555
[TBL] [Abstract][Full Text] [Related]
30. Development of a pair of real-time loop mediated isothermal amplification assays for detection of Yersinia pestis, the causative agent of plague.
Singh R; Pal V; Tripathi NK; Goel AK
Mol Cell Probes; 2020 Dec; 54():101670. PubMed ID: 33132200
[TBL] [Abstract][Full Text] [Related]
31. Critical Comparison between Large and Mini Vertical Flow Immunoassay Platforms for
Devadhasan JP; Gu J; Chen P; Smith S; Thomas B; Gates-Hollingsworth M; Hau D; Pandit S; AuCoin D; Zenhausern F
Anal Chem; 2021 Jul; 93(27):9337-9344. PubMed ID: 33989499
[No Abstract] [Full Text] [Related]
32. The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague.
Derewenda U; Mateja A; Devedjiev Y; Routzahn KM; Evdokimov AG; Derewenda ZS; Waugh DS
Structure; 2004 Feb; 12(2):301-6. PubMed ID: 14962390
[TBL] [Abstract][Full Text] [Related]
33. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
[TBL] [Abstract][Full Text] [Related]
34. Plague vaccines and the molecular basis of immunity against Yersinia pestis.
Quenee LE; Schneewind O
Hum Vaccin; 2009 Dec; 5(12):817-23. PubMed ID: 19786842
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis.
Pouliot K; Pan N; Wang S; Lu S; Lien E; Goguen JD
Infect Immun; 2007 Jul; 75(7):3571-80. PubMed ID: 17438030
[TBL] [Abstract][Full Text] [Related]
36. Use of magnetic nanotrap particles in capturing Yersinia pestis virulence factors, nucleic acids and bacteria.
Ii AN; Lin SC; Lepene B; Zhou W; Kehn-Hall K; van Hoek ML
J Nanobiotechnology; 2021 Jun; 19(1):186. PubMed ID: 34154629
[TBL] [Abstract][Full Text] [Related]
37. Detection and isolation of Yersinia pestis without fraction 1 antigen by monoclonal antibody in foods and water.
Zhao T; Zhao P; Doyle MP
J Food Prot; 2012 Sep; 75(9):1555-61. PubMed ID: 22947461
[TBL] [Abstract][Full Text] [Related]
38. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
39. Antigenic profiling of yersinia pestis infection in the Wyoming coyote (Canis latrans).
Vernati G; Edwards WH; Rocke TE; Little SF; Andrews GP
J Wildl Dis; 2011 Jan; 47(1):21-9. PubMed ID: 21269993
[TBL] [Abstract][Full Text] [Related]
40. Antibodies and cytokines independently protect against pneumonic plague.
Kummer LW; Szaba FM; Parent MA; Adamovicz JJ; Hill J; Johnson LL; Smiley ST
Vaccine; 2008 Dec; 26(52):6901-7. PubMed ID: 18926869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
